Proceedings From the 1st International Conference 'Current Concepts and Controversies in Gynecologic and Urologic Oncology' von Matylevich, Olga, Mavrichev, Sergey, Pletnev, Andrei, Evmenenko, Alesya, Shevchuk, Aleksey, Suslova, Valentina, Taranenko, Sergey, Dolomanova, Elena, Rovsky, Dmitry, Portyanko, Anna, Brown, Jubilee, Naumann, Robert Wendel, Schmeler, Kathleen, Plotkin, Anna, Michaelson, Sophia, Eiken, Mary, Trimble, Edward, Randall, Thomas

Volltext

Vaginal Cuff Closure During Laparoscopic Hysterectomy Comparing the EndoStitch and RD-180 Suturing Devices von Nair, Anjana R., Harris, Rachel A., Naumann, Robert Wendel

Volltext

Abstract CT160: A Phase I, open-label, safety, pharmacokinetic, and preliminary efficacy study of STRO-002, an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), in... von Naumann, Robert Wendel, Uyar, Denise S., Schilder, Russell J., Palumbo, Michael A., DeAlmeida, Venita, Matheny, Shannon L., Molina, Arturo

Volltext

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant O... von NAUMANN, R. Wendel, COLEMAN, Robert L, GERSH, Robert H, TENERIELLO, Michael G, HARB, Wael A, KONSTANTINOPOULOS, Panagiotis A, PENSON, Richard T, SYMANOWSKI, James T, LOVEJOY, Chandra D, LEAMON, Christopher P, MORGENSTERN, David E, MESSMANN, Richard A, BURGER, Robert A, SAUSVILLE, Edward A, KUTARSKA, Elzbieta, GHAMANDE, Sharad A, GABRAIL, Nashat Y, DEPASQUALE, Stephen E, NOWARA, Elzbieta, GILBERT, Lucy

Volltext

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer von Naumann, R. Wendel, Coleman, Robert L.

Volltext

Phase III trials in ovarian cancer: The evolving landscape of front line therapy von Naumann, R. Wendel, Coleman, Robert L., Brown, Jubilee, Moore, Kathleen N.

Volltext

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer von Fu, Siqing, Corr, Bradley R, Culm-Merdek, Kerry, Mockbee, Colleen, Youssoufian, Hagop, Stagg, Robert, Naumann, R Wendel, Wenham, Robert M, Rosengarten, Rafael D, Benjamin, Laura, Hamilton, Erika Paige, Moore, Kathleen N

Volltext

Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial von Costales, Anthony B., Crane, Erin K., Chambers, Laura, Yao, Meng, Chau, Danielle, Naumann, Wendel R., Debernardo, Robert, Ricci, Stephanie, Rose, Peter G., Michener, Chad M.

Volltext

A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling von Brown, Jubilee, Athens, Aly, Tait, David L, Crane, Erin K, Higgins, Robert V, Naumann, R Wendel, Gusic, Lejla Hadzikadic, Amacker-North, Lisa

Volltext

Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444] von Naumann, R. Wendel, Coleman, Robert L., Brown, Jubilee, Moore, Kathleen N.

Volltext

When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer von Brown, Jubilee, Drury, Lane, Crane, Erin K., Anderson, William E., Tait, David L., Higgins, Robert V., Naumann, R. Wendel

Volltext

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer von Liu, Joyce F, Ray-Coquard, Isabelle, Selle, Frederic, Poveda, Andrés M, Cibula, David, Hirte, Hal, Hilpert, Felix, Raspagliesi, Francesco, Gladieff, Laurence, Harter, Philipp, Siena, Salvatore, Del Campo, Josep Maria, Tabah-Fisch, Isabelle, Pearlberg, Joseph, Moyo, Victor, Riahi, Kaveh, Nering, Rachel, Kubasek, William, Adiwijaya, Bambang, Czibere, Akos, Naumann, R Wendel, Coleman, Robert L, Vergote, Ignace, MacBeath, Gavin, Pujade-Lauraine, Eric

Volltext

Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer von Naumann, R. Wendel, Morris, Jacob C., Tait, David L., Higgins, Robert V., Crane, Erin K., Drury, Lane K., Amacker-North, Lisa, Templin, Megan, Brown, Jubilee

Volltext

European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies von Herzog, Thomas J., Secord, Angeles Alvarez, Coleman, Robert L., Naumann, R. Wendel

Volltext

RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer von O'Malley, David M, Randall, Leslie M, Jackson, Camille Gunderson, Coleman, Robert L, Hays, John L, Moore, Kathleen N, Naumann, R Wendel, Rocconi, Rodney P, Slomovitz, Brian M, Tewari, Krishnansu S, Ancukiewicz, Marek, Feliu, Waldo Ortuzar, Monk, Bradley J

Volltext

The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005 von Naumann, R. Wendel, Coleman, Robert L

Volltext

REFRaME-O1/ENGOT-OV79/GOG-3086: A phase II/III, open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator's choice of chemotherapy in women... von Naumann, R. Wendel, Lee, Jung-Yun, Herzog, Thomas, Coleman, Robert, Coquard, Isabelle Ray, Miller, Rowan, Lu, Lin, Berman, Craig, Sadeia, Muaz, Oaknin, Ana

Volltext

Clinical trial methodology in rare gynecologic tumor research: Strategies for success von Brown, Jubilee, Naumann, R. Wendel, Brady, William E., Coleman, Robert L., Moore, Kathleen N., Gershenson, David M.

Volltext

Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer von Naumann, R. Wendel, Sukumvanich, Paniti, Edwards, Robert P

Volltext

Author’s Reply von Brown, Jubilee, Drury, Lane, Crane, Erin K., Anderson, William E., Tait, David L., Higgins, Robert V., Naumann, R. Wendel

Volltext